Johnson & Johnson faces multibillion opioids lawsuit that could upend big pharma
Oklahoma is suing Johnson & Johnson in a multibillion-dollar lawsuit to hold the drug giant responsible for its opioid addiction epidemic.
Day after day, the memos flashing across screens in an Oklahoma courtroom have jarred with the family-friendly public image of Johnson & Johnson, the pharmaceutical giant best known for baby powder and Band-Aid.
In one missive, a sales representative dismissed a doctor’s fears that patients might become addicted to the company’s opioid painkillers by telling him those who didn’t die probably wouldn’t get hooked. Another proposes targeting sales of the powerfully addictive drugs at those most at risk: men under 40.
As the state of Oklahoma’s multibillion-dollar lawsuit against Johnson & Johnson has unfolded over the past month, the company has struggled to explain marketing strategies its accusers say dangerously misrepresented the risk of opioid addiction to doctors, manipulated medical research, and helped drive an epidemic that has claimed 400,000 lives over the past two decades.
TriMark Legal Funding provides non-recourse pre settlement lawsuit funding and post settlement loans to injured plaintiffs nationwide. Call (877) 932-2628 with questions or to apply for funding.
This post originally appeared here: https://www.theguardian.com/us-news/2019/jun/22/johnson-and-johnson-opioids-crisis-lawsuit-latest-trial
Click here to see the full original article.